UroGen Pharma Ltd. Variable Lease, Cost
UroGen Pharma Ltd. (URGN) reported Variable Lease, Cost of $113.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-05
- UroGen Pharma Ltd. variable lease, cost for the quarter ending 2026-06-30 was $113.00K, a 653.33% increase year-over-year.
- UroGen Pharma Ltd. variable lease, cost for the quarter ending 2026-03-31 was $55.00K, a 323.08% increase year-over-year.
- UroGen Pharma Ltd. variable lease, cost for the quarter ending 2025-12-31 was $18.00K, a 38.46% increase year-over-year.
- UroGen Pharma Ltd. variable lease, cost for the quarter ending 2025-09-30 was $18.00K, a 28.57% increase year-over-year.
- UroGen Pharma Ltd. variable lease, cost for fiscal 2025 was $65.00K, a 7.14% decline from fiscal 2024.
- UroGen Pharma Ltd. variable lease, cost for fiscal 2024 was $70.00K, a 4.11% decline from fiscal 2023.
- UroGen Pharma Ltd. variable lease, cost for fiscal 2023 was $73.00K, a 12.31% increase from fiscal 2022.
- UroGen Pharma Ltd. variable lease, cost for fiscal 2022 was $65.00K, a 1.52% decline from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $113.00K 10-Q · filed 2026-08-05 | $168.00K 10-Q · filed 2026-08-05 | $186.00K derived: sum of 3 quarters · filed 2026-08-05 | $204.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $55.00K 10-Q · filed 2026-05-06 | $73.00K derived: sum of 2 quarters · filed 2026-05-06 | $91.00K derived: sum of 3 quarters · filed 2026-05-06 | $106.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $36.00K derived: sum of 2 quarters · filed 2026-03-02 | $51.00K derived: sum of 3 quarters · filed 2026-08-05 | $65.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | $18.00K 10-Q · filed 2025-11-06 | $33.00K derived: sum of 2 quarters · filed 2026-08-05 | $47.00K 10-Q · filed 2025-11-06 | $59.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $15.00K 10-Q · filed 2026-08-05 | $28.00K 10-Q · filed 2026-08-05 | $41.00K derived: sum of 3 quarters · filed 2026-08-05 | $55.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $13.00K 10-Q · filed 2026-05-06 | $26.00K derived: sum of 2 quarters · filed 2026-05-06 | $40.00K derived: sum of 3 quarters · filed 2026-05-06 | $54.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $27.00K derived: sum of 2 quarters · filed 2026-03-02 | $41.00K derived: sum of 3 quarters · filed 2026-03-02 | $70.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $14.00K 10-Q · filed 2025-11-06 | $28.00K derived: sum of 2 quarters · filed 2025-11-06 | $57.00K 10-Q · filed 2025-11-06 | $79.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $14.00K 10-Q · filed 2025-08-07 | $43.00K 10-Q · filed 2025-08-07 | $65.00K derived: sum of 3 quarters · filed 2025-08-07 | $78.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $29.00K 10-Q · filed 2025-05-12 | $51.00K derived: sum of 2 quarters · filed 2025-05-12 | $64.00K derived: sum of 3 quarters · filed 2025-05-12 | $83.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $35.00K derived: sum of 2 quarters · filed 2025-03-10 | $54.00K derived: sum of 3 quarters · filed 2025-03-10 | $73.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $13.00K 10-Q · filed 2024-11-06 | $32.00K derived: sum of 2 quarters · filed 2024-11-06 | $51.00K 10-Q · filed 2024-11-06 | $64.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $19.00K 10-Q · filed 2024-08-13 | $38.00K 10-Q · filed 2024-08-13 | $51.00K derived: sum of 3 quarters · filed 2024-08-13 | $67.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $19.00K 10-Q · filed 2024-05-13 | $32.00K derived: sum of 2 quarters · filed 2024-05-13 | $48.00K derived: sum of 3 quarters · filed 2024-05-13 | $67.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $29.00K derived: sum of 2 quarters · filed 2024-03-14 | $48.00K derived: sum of 3 quarters · filed 2024-03-14 | $65.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | $16.00K 10-Q · filed 2023-11-14 | $35.00K derived: sum of 2 quarters · filed 2023-11-14 | $52.00K 10-Q · filed 2023-11-14 | $67.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $19.00K 10-Q · filed 2023-08-10 | $36.00K 10-Q · filed 2023-08-10 | $51.00K derived: sum of 3 quarters · filed 2023-08-10 | $66.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $17.00K 10-Q · filed 2023-05-11 | $32.00K derived: sum of 2 quarters · filed 2023-05-11 | $47.00K derived: sum of 3 quarters · filed 2023-05-11 | $61.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $30.00K derived: sum of 2 quarters · filed 2023-03-24 | $44.00K derived: sum of 3 quarters · filed 2023-03-24 | $66.00K 10-K · filed 2023-03-24 |
| 2021-09-30 | $15.00K 10-Q · filed 2022-11-10 | $29.00K derived: sum of 2 quarters · filed 2022-11-10 | $51.00K 10-Q · filed 2022-11-10 | $66.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $14.00K 10-Q · filed 2022-08-11 | $36.00K 10-Q · filed 2022-08-11 | $51.00K derived: sum of 3 quarters · filed 2022-08-11 | $79.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $22.00K 10-Q · filed 2022-05-10 | $37.00K derived: sum of 2 quarters · filed 2022-05-10 | $65.00K derived: sum of 3 quarters · filed 2022-05-10 | $95.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $43.00K derived: sum of 2 quarters · filed 2022-03-21 | $73.00K derived: sum of 3 quarters · filed 2022-03-21 | $129.00K 10-K · filed 2022-03-21 |
| 2020-09-30 | $28.00K 10-Q · filed 2021-11-15 | $58.00K derived: sum of 2 quarters · filed 2021-11-15 | $114.00K 10-Q · filed 2021-11-15 | $138.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $30.00K 10-Q · filed 2021-08-04 | $86.00K 10-Q · filed 2021-08-04 | $110.00K derived: sum of 3 quarters · filed 2021-08-04 | $132.00K derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $56.00K 10-Q · filed 2020-05-07 | $80.00K derived: sum of 2 quarters · filed 2020-05-07 | $102.00K derived: sum of 3 quarters · filed 2020-05-07 | $131.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $46.00K derived: sum of 2 quarters · filed 2020-03-02 | $75.00K derived: sum of 3 quarters · filed 2020-03-02 | $105.00K 10-K · filed 2020-03-02 |
| 2019-09-30 | $22.00K 10-Q · filed 2019-11-12 | $51.00K derived: sum of 2 quarters · filed 2019-11-12 | $81.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $29.00K 10-Q · filed 2019-08-09 | $59.00K 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | $30.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |